(-)-Epigallocatechin-3-gallate decreases thrombin/paclitaxel-induced endothelial tissue factor expression via the inhibition of c-Jun terminal NH2 kinase phosphorylation

Biochemical and Biophysical Research Communications

Volumn 391, Issue 1, 2010, Pages 716-721

  Wang, Huang Joe ^a,b   Lo, Wan Yu ^b,c   Lu, Te Ling ^c   Huang, Haimei ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

( ) Epigallocatechin 3 gallate; Drug eluting stent; Endothelial cells; Paclitaxel; Thrombin; Tissue factor

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; EPIGALLOCATECHIN GALLATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PACLITAXEL; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOTAGMIN I; THROMBIN; THROMBOPLASTIN;

AORTA; ARTICLE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ANTHRACENES; CATECHIN; CELLS, CULTURED; DRUG-ELUTING STENTS; ENDOTHELIUM, VASCULAR; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; PACLITAXEL; PHOSPHORYLATION; THROMBIN; THROMBOPLASTIN; TRANSCRIPTION FACTOR RELA;

EID: 72949094880     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.11.126     Document Type: Article

References (31)

1. Maluenda G., Lemesle G., and Waksman R. A critical appraisal of the safety and efficacy of drug-eluting stents. Clin. Pharmacol. Ther. 85 (2009) 474-480
2. Roy P., Bonello L., Torguson R., de Labriolle A., et al. Impact of "nuisance" bleeding on clopidogrel compliance in patients undergoing intracoronary drug-eluting stent implantation. Am. J. Cardiol. 102 (2008) 1614-1617
3. Gori A.M., Marcucci R., Migliorini A., et al. Incidence and clinical impact of dual nonresponsiveness to aspirin and clopidogrel in patients with drug-eluting stents. J. Am. Coll. Cardiol. 52 (2008) 734-739
4. Mega J.L., Close S.L., Wiviott S.D., et al. Cytochrome p-450 polymorphisms and response to clopidogrel. N. Engl. J. Med. 360 (2009) 354-362
5. Parry T.J., Brosius R., Thyagarajan R., et al. Drug-eluting stents: sirolimus and paclitaxel differentially affect cultured cells and injured arteries. Eur. J. Pharmacol. 524 (2005) 19-29
6. Stettler C., Wandel S., Allemann S., et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 370 (2007) 937-948
7. Mackman N., Tilley R.E., and Key N.S. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 1687-1693
8. Gyöngyösi M., Strehblow C., Sperker W., et al. Platelet activation and high tissue factor level predict acute stent thrombosis in pig coronary arteries: prothrombogenic response of drug-eluting or bare stent implantation within the first 24 hours. Thromb. Haemost. 96 (2006) 202-209
9. Steffel J., Luscher T.F., and Tanner F.C. Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation 113 (2006) 722-731
10. 2 kinase activation. Circ. Res. 99 (2006) 149-155
11. Wang H.J., Huang H., Chuang Y.C., and Huang H.C. Paclitaxel induces up-regulation of tissue factor in human aortic endothelial cells. Int. Immunopharmacol. 9 (2009) 144-147
12. Camici G.G., Steffel J., Akhmedov A., et al. Dimethyl sulfoxide inhibits tissue factor expression, thrombus formation, and vascular smooth muscle cell activation: a potential treatment strategy for drug-eluting stents. Circulation 114 (2006) 1512-1521
13. Khan N., Afaq F., Saleem M., et al. Targeting multiple signaling pathway by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res. 66 (2006) 2500-2505
14. Cheng T.O. All teas are not equal: the Chinese green tea and cardiovascular death. Int. J. Cardiol. 108 (2006) 301-308
15. Wolfram S. Effects of green tea and EGCG on cardiovascular and metabolic health. J. Am. Coll. Nutr. 26 (2007) 373S-388S
16. Pietta P.G. Flavonoids as antioxidants. J. Nat. Prod. 63 (2000) 1035-1042
17. Kang W.S., Lim I.H., Yuk D.Y., et al. Antithrombotic activities of green tea catechins and (-)-epigallocatechin gallate. Thromb. Res. 96 (1999) 229-237
18. Stampfuss J.J., Schrör K., and Weber A.A. Green tea catechins containing a galloyl group in the 3′ position inhibit tissue factor-induced thrombin generation. Thromb. Haemost. 93 (2005) 1200-1201
19. Vita J.A. Tea consumption and cardiovascular disease: effects in endothelial dysfunction. J. Nutr. 133 (2003) 3293S-3297S
20. Biesalski H.K. Polyphenols and inflammation: basic interactions. Curr. Opin. Clin. Nutr. Metab. Care 10 (2007) 724-728
21. Pendurthi U.R., Williams J.T., and Rao L.V. Resveratrol, a polyphenolic compound found in wine, inhibits tissue factor expression in vascular cells: a possible mechanism for the cardiovascular benefits associated with moderate consumption of wine. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 419-426
22. Pendurthi U.R., and Rao L.V. Effect of wine phenolics and stilbene analogues on tissue factor expression in endothelial cells. Thromb. Res. 106 (2002) 205-211
23. Williams R.J., Spencer J.P., and Rice-Evans C. Flavonoids: antioxidants or signalling molecules?. Free Radic. Biol. Med. 36 (2004) 838-849
24. Choi J.S., Choi Y.J., Shin S.Y., et al. Dietary flavonoids differentially reduce oxidized LDL-induced apoptosis in human endothelial cells: role of MAPK- and JAK/STAT-signaling. J. Nutr. 138 (2008) 983-990
25. Dong L., Ma W.Y., Huang C., et al. Inhibition of tumor promoter-induced activated protein-1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins. Cancer Res. 57 (1997) 4414-4419
26. Mackman N. Regulation of the tissue factor gene. Thromb. Haemost. 78 (1997) 747-754
27. Hess J., Angel P., and Schorpp-Kistner M. AP-1 subunits: quarrel and harmony among siblings. J. Cell Sci. 117 (2004) 5965-5973
28. Afaq F., Adhami V.M., Ahmad N., and Mukhtar H. Inhibition of ultraviolet B-mediated activation of nuclear factor κB in normal human epidermal keratinocytes by green tea constituent (-)-epigallocatechin-3-gallate. Oncogene 22 (2003) 1035-1044
29. Syed D.N., Afaq F., Kweon M.H., et al. Green tea polyphenol EGCG suppresses cigarette smoke condensate-induced NF-κB activation in normal human bronchial epithelial cell. Oncogene 26 (2007) 673-682
30. Choi K.C., Jung M.G., Lee Y.H., et al. Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation. Cancer Res. 69 (2009) 583-592
31. E.W. Holy, S.F. Stämpfli, A. Akhmedov, et al., Laminin receptor activation inhibits endothelial tissue factor expression, J. Mol. Cell. Cardiol. (2009), doi:10.1016/j.yjmcc.2009.08.012.